Patrick Coyne to Pain, Intractable
This is a "connection" page, showing publications Patrick Coyne has written about Pain, Intractable.
Connection Strength
1.832
-
Dexmedetomidine: exploring its potential role and dosing guideline for its use in intractable pain in the palliative care setting. J Pain Palliat Care Pharmacother. 2010 Dec; 24(4):384-6.
Score: 0.359
-
Epidural screening before intrathecal analgesia. J Pain Palliat Care Pharmacother. 2008; 22(1):69-70.
Score: 0.293
-
Effectively starting and titrating intrathecal analgesic therapy in patients with refractory cancer pain. Clin J Oncol Nurs. 2005 Oct; 9(5):581-3.
Score: 0.251
-
Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients. J Palliat Med. 2005 Aug; 8(4):736-42.
Score: 0.248
-
Pain management, including intrathecal pumps. Curr Oncol Rep. 2004 Jul; 6(4):291-6.
Score: 0.230
-
When the world health organization analgesic therapies ladder fails: the role of invasive analgesic therapies. Oncol Nurs Forum. 2003 Sep-Oct; 30(5):777-83.
Score: 0.217
-
Fosaprepitant for the Management of Refractory Pain in a Patient with Cancer-Related Dermatomyositis. J Palliat Med. 2017 12; 20(12):1415-1419.
Score: 0.143
-
Dexmedetomidine as an adjuvant analgesic for intractable cancer pain. J Palliat Med. 2011 Mar; 14(3):371-3.
Score: 0.091